Literature DB >> 15663506

Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.

M O Oztas1, M Onder, M A Gurer, N Bukan, B Sancak.   

Abstract

Inflammation in Behcet's disease is thought to be mediated by cytokines derived from T-helper type 1 (Th1) lymphocytes. In this study, we tried to determine serum interleukin (IL)-18 and tumour necrosis factor (TNF)-alpha levels of patients with Behcet's disease. Twenty-seven patients with active Behcet's disease, and 20 healthy control subjects were included in this study. Differences between mean serum IL-18 and TNF-alpha level of patients with Behcet's disease were significantly increased when compared with the control group. A significant correlation was found between serum IL-18 and TNF-alpha levels of Behcet patients (rs = 0.627, P < 0.0001). IL-18 and TNF-alpha levels may be related to disease pathogenesis. Increased levels of IL-18 also support Th1 predominance in Behcet's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15663506     DOI: 10.1111/j.1365-2230.2004.01684.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  23 in total

1.  Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?

Authors:  U Musabak; S Pay; H Erdem; I Simsek; A Pekel; A Dinc; A Sengul
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

2.  LPS-stimulated production of TNF-alpha by peripheral blood monocytes in patients with Behcet's disease.

Authors:  Gleb Slobodin; Yazeed Toukan; Itzhak Rosner; Michael Rozenbaum; Nina Boulman; Elsa Pavlotzky; Aharon Kessel; Elias Toubi
Journal:  Clin Rheumatol       Date:  2006-07-29       Impact factor: 2.980

3.  Serum Cytokine Levels in Behçet's Disease.

Authors:  Zeynep Meltem Akkurt; Mehtap Bozkurt; Derya Uçmak; Hatice Yüksel; Haydar Uçak; Bilal Sula; Zeynep Gürsel Özkurt; Mehmet Yildiz; Dicle Akdeniz; Mustafa Arica
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

4.  IL18 polymorphism is associated with Behçet's disease but not lupus in patients from Turkey.

Authors:  Jasmine Htoon; Ajay Nadig; Travis Hughes; Sule Yavuz; Haner Direskeneli; Güher Saruhan-Direskeneli; Amr H Sawalha
Journal:  J Rheumatol       Date:  2011-05       Impact factor: 4.666

5.  Antistreptolysin O Levels in Patients with Behcet's Disease.

Authors:  Hulya Uzkeser; Saliha Karatay; Kadir Yildirim; Ali Karakuzu; Muhammed Hamidullah Uyanik
Journal:  Eurasian J Med       Date:  2011-12

6.  TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet's Disease.

Authors:  Mortaza Bonyadi; Zohreh Jahanafrooz; Mohsen Esmaeili; Susan Kolahi; Alireza Khabazi; Ali Asghar Ebrahimi; Mehrzad Hajialilo; Saeed Dastgiri
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

7.  Association of TNFA promoter region haplotype in Behçet's Disease.

Authors:  KyungSook Park; NaYoung Kim; JungHyun Nam; Dongsik Bang; Eun-So Lee
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

8.  Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis.

Authors:  Esin Aktas Cetin; Fulya Cosan; Umut Can Kucuksezer; Sema Bilgic; Yonca Cagatay; Ahmet Gul; Gunnur Deniz
Journal:  Rheumatol Int       Date:  2012-05-11       Impact factor: 2.631

9.  Vitamin D status in patients with Behcet's Disease.

Authors:  Saliha Karatay; Kadir Yildirim; Ali Karakuzu; Ahmet Kiziltunc; Ragip Ismail Engin; Yonca Bavli Eren; Akin Aktas
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study.

Authors:  Eun Chun Han; Sung Bin Cho; Keun Jae Ahn; Sang Ho Oh; Jihyun Kim; Dong Soo Kim; Kwang Hoon Lee; Dongsik Bang
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.